Trials / Conditions / Rare Disease
Rare Disease
4 registered clinical trials studyying Rare Disease — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platfo NCT07147465 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | Longitudinal Registry Including Patients Treated With Heavy Particles NCT05203250 | CNAO National Center of Oncological Hadrontherapy | — |
| Terminated | Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors NCT02938793 | Prisma Health-Upstate | Phase 2 |
| Enrolling By Invitation | Idiopathic Diseases of Man NCT01440218 | Scripps Translational Science Institute | — |